Search
Search
About
Log in
Join
Experiences with
Targeted therapy
Posts
Communities
16,403 public posts
Filter results
Interesting new targeted therapy trial
https://www.transcodetherapeutics.com TransCode’s lead therapeutic candidate, TTX-MC138, is a
targeted
therapy
designed to treat cancer patients with metastatic cancer, an area traditionally overlooked because, from a therapeutic perspective, non-metastatic and metastatic tumor cells are often viewed
https://www.transcodetherapeutics.com TransCode’s lead therapeutic candidate, TTX-MC138, is a
targeted
therapy
designed to treat cancer patients with metastatic cancer, an area traditionally overlooked because, from a therapeutic perspective, non-metastatic and metastatic tumor cells are often viewed
Best521
in
SHARE Metastatic Breast Cancer
2 months ago
Newly diagnosed with HCC
The GIST tumors were shrinking out of site thanks to be taking Gleevec, a
targeted
therapy
drug. My surgeon could not safely resect the HCC tumor so I am going to have the Y90 procedure. I am happy to have found this group and hope to learn from you.
The GIST tumors were shrinking out of site thanks to be taking Gleevec, a
targeted
therapy
drug. My surgeon could not safely resect the HCC tumor so I am going to have the Y90 procedure. I am happy to have found this group and hope to learn from you.
Dachshund45
in
Blue Faery Liver Cancer
6 days ago
Not PCa related, but interesting new delivery techniques:
This intelligent nanomachine with controlled release of anti-cancer drug in specific cancer cell subtypes can reduce the side effect to normal cells and facilitate the
targeted
therapy
, which is promising as a theranostics nanoplatform in precise medicine." We are already at subtype delivery?
This intelligent nanomachine with controlled release of anti-cancer drug in specific cancer cell subtypes can reduce the side effect to normal cells and facilitate the
targeted
therapy
, which is promising as a theranostics nanoplatform in precise medicine." We are already at subtype delivery?
Maxone73
in
Advanced Prostate Cancer
3 months ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
INSURANCE DENIED - STAGE 4 BREAST CANCER
HI everyone, my mother is diagnosed with stage 4 breast cancer and doctor to give phesgo ( pertuzumab and transtuzumab) but insurance people told its a immunotheraphy so they wont apporve, but my oncologist told its a
targeted
therapy
not immuno. my insurance is new india insurance under tpa being mediassist.Did
HI everyone, my mother is diagnosed with stage 4 breast cancer and doctor to give phesgo ( pertuzumab and transtuzumab) but insurance people told its a immunotheraphy so they wont apporve, but my oncologist told its a
targeted
therapy
not immuno. my insurance is new india insurance under tpa being mediassist.Did
Srikalakm
in
Breast Cancer India
4 months ago
Capiverstib
Anyone heard of or started this new FDA approved
targeted
therapy
? What is your experience or understanding?
Anyone heard of or started this new FDA approved
targeted
therapy
? What is your experience or understanding?
Yikes123
in
SHARE Metastatic Breast Cancer
7 months ago
More about Cu-67 PSMA : it seems better than Pluvicto (Lutetium) and it looks like experts are pushing it toward first line treatment!
Utilizing copper 64 for precise imaging and copper 67 for
targeted
therapy
, the trial has shown promising preclinical and early clinical results with significant tumor targeting and low toxicity. Benefits include fewer required doses, improved patient convenience, and scalable production.
Utilizing copper 64 for precise imaging and copper 67 for
targeted
therapy
, the trial has shown promising preclinical and early clinical results with significant tumor targeting and low toxicity. Benefits include fewer required doses, improved patient convenience, and scalable production.
Maxone73
in
Advanced Prostate Cancer
8 days ago
Recurrence
I have had a number of reoccurrences but want to share that so far I’ve been knocking them back with various treatments, whether it be chemo, radiation,
targeted
therapy
, immunotherapy.
I have had a number of reoccurrences but want to share that so far I’ve been knocking them back with various treatments, whether it be chemo, radiation,
targeted
therapy
, immunotherapy.
Leniko
in
My Ovacome
2 months ago
Recurrence
I have had a number of reoccurrences but want to share that so far I’ve been knocking them back with various treatments, whether it be chemo, radiation,
targeted
therapy
, immunotherapy.
I have had a number of reoccurrences but want to share that so far I’ve been knocking them back with various treatments, whether it be chemo, radiation,
targeted
therapy
, immunotherapy.
Leniko
in
My Ovacome
2 months ago
insurance issue
These people are not approving phesgo which is
targeted
therapy
telling that it is as immunotherapy instead of
targeted
. and immunotherapy are not covered in insurance policy .
These people are not approving phesgo which is
targeted
therapy
telling that it is as immunotherapy instead of
targeted
. and immunotherapy are not covered in insurance policy .
Srikalakm
in
Breast Cancer India
4 months ago
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer
This subgroup presents an intriguing opportunity for
targeted
therapy
focusing on glutamine metabolism.
This subgroup presents an intriguing opportunity for
targeted
therapy
focusing on glutamine metabolism.
God_Loves_Me
in
Advanced Prostate Cancer
2 months ago
stage 3b/c inoperable non small cell lung cancer. Cannot tolerate durvalumab, (pneumonitis) No mutations - any hope?
Eventually a pet tac and broncoscopy in January showed I have a new 5cm inoperable tumour , with no mutations, so. no
targeted
therapy
..
Eventually a pet tac and broncoscopy in January showed I have a new 5cm inoperable tumour , with no mutations, so. no
targeted
therapy
..
ohayeai
in
The Roy Castle Lung Cancer Foundation
5 months ago
Treatment stopped
When the NHS originally said months, I said I felt like they we’re writing dad off due to his and following my research, said we were arranging private liquid biopsy, NHS then agreed to do the liquid one and the result was the
targeted
therapy
.
When the NHS originally said months, I said I felt like they we’re writing dad off due to his and following my research, said we were arranging private liquid biopsy, NHS then agreed to do the liquid one and the result was the
targeted
therapy
.
Adaughter
in
The Roy Castle Lung Cancer Foundation
4 months ago
Research Participation Opportunity!
therapy
(such as Lynparza, Rubraca, and Zejula) Those who qualify and complete the virtual interview will be paid $125 USD if you are a US participant and £80 GBP if you are a UK participant.
therapy
(such as Lynparza, Rubraca, and Zejula) Those who qualify and complete the virtual interview will be paid $125 USD if you are a US participant and £80 GBP if you are a UK participant.
SHAREPrograms
Partner
in
SHARE Ovarian Cancer Support
6 months ago
Update on FIL -Venetoclax as a Monotherapy, Pancytopenia and Myelodysplasia
We were also told it wouldn't affect his Pancytopenia and Myelodysplasia as it was a
targeted
therapy
. It took 6 months for him to be started on the treatment at this end.
We were also told it wouldn't affect his Pancytopenia and Myelodysplasia as it was a
targeted
therapy
. It took 6 months for him to be started on the treatment at this end.
JoeMcDote
in
CLL Support
5 days ago
Thank you Angela for sharing your story!
Shortly after returning home from hospital I started on
targeted
therapy
to treat my melanoma which has been working really well ever since.
Shortly after returning home from hospital I started on
targeted
therapy
to treat my melanoma which has been working really well ever since.
SkcinHQ
Partner
in
Skin Cancer UK
2 months ago
DENOSUNAB
However, as my
targeted
therapy
treatment (Brigatinib) is working, I am enquiring whether it is still necessary for me to continue with the Denosunab, and if I do have to, the possible reasons why?
However, as my
targeted
therapy
treatment (Brigatinib) is working, I am enquiring whether it is still necessary for me to continue with the Denosunab, and if I do have to, the possible reasons why?
Gymbuddie
in
The Roy Castle Lung Cancer Foundation
9 months ago
ONLINE SUPPORT GROUPS
As this is quite a specific group who are on
targeted
therapy
, it is nice to have people who are in a similar boat. [u]New group starting on Wednesday 20th of March. [/u]This group will run weekly for 8 weeks every Wednesday evening - 6.30-7.30pm.
As this is quite a specific group who are on
targeted
therapy
, it is nice to have people who are in a similar boat. [u]New group starting on Wednesday 20th of March. [/u]This group will run weekly for 8 weeks every Wednesday evening - 6.30-7.30pm.
ConnectRoyCastle
Administrator
in
The Roy Castle Lung Cancer Foundation
5 months ago
Transformation of Richter's Transformation Treatment to combination targeted therapy - tislelizumab +zanubrutinib (ASH 2023)
Richter's Transformation treatments are typically fixed term R-CHOP*, or modifications of that chemoimmunity therapy. So it's encouraging to hear that [i]"In a phase 2 trial, anti-PD-1 inibitor tislelizumab + next gen BTK inhibitor zanubrutinib had an overall response rate of 58.3% in patients with Richter's
Richter's Transformation treatments are typically fixed term R-CHOP*, or modifications of that chemoimmunity therapy. So it's encouraging to hear that [i]"In a phase 2 trial, anti-PD-1 inibitor tislelizumab + next gen BTK inhibitor zanubrutinib had an overall response rate of 58.3% in patients with Richter's
AussieNeil
Partner
in
CLL Support
7 months ago
What is role of hormonal therapy drug when taken with targeted therapy, eg Piqray or Ibrance?
I want to better understand the role of the hormone
therapy
eg Faslodex when taken with
targeted
therapy
such as Ibrance. Does it just reduce the amount of estrogen available to the cell and “lightens the load” on the
targeted
therapy
? Or is there a more complex interaction between the two drugs?
I want to better understand the role of the hormone
therapy
eg Faslodex when taken with
targeted
therapy
such as Ibrance. Does it just reduce the amount of estrogen available to the cell and “lightens the load” on the
targeted
therapy
? Or is there a more complex interaction between the two drugs?
HelenWi
in
SHARE Metastatic Breast Cancer
9 months ago
Targeted therapy drugs
I am interested in people who have taken Zanubrutinib. Did you half to go through a lot of hassle getting the drug? How many preliminary’s are involved before they say OK? I am interested in the stories of individuals that have taken the drug.
I am interested in people who have taken Zanubrutinib. Did you half to go through a lot of hassle getting the drug? How many preliminary’s are involved before they say OK? I am interested in the stories of individuals that have taken the drug.
Tupelomojo
in
CLL Support
11 months ago
1
2
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
4498 results
Thyroid UK
2377 results
Endometriosis UK
1861 results
View top 10 communities
Sort by
Most Relevant
Newest